leisure time -WSS

leisure time

author：hotspot 2025-09-29 21:21:05 - browse：99

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Mega Millions pot grows to $1.25 billion after no winner

WSS

What the US credit downgrade means for the economy, your finances

NIH launches clinical trials and new research office for long Covid

Takeaways from AdvaMed, the largest medical devices conference

Humana CEO Bruce Broussard to step down in 2024

‘Oppenheimer’ and the risks of AI in health care

Peter Marks talks Operation Warp Speed for Rare Diseases

hotspot

leisure time

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Adults seen as increasingly susceptible to measles

Virginia high school admissions case could be legal follow

There’s no way to know how good AI health technologies are

The high cost of giving birth even with insurance

National panel will explore requiring free Covid tests

Dobbs anniversary: the lost opportunity of abortion as health care

The high personal cost of affirmative action for Black doctors

Novavax promises a turnaround & Lilly roils the obesity market

Adults seen as increasingly susceptible to measles

entertainment

European regulators consider appeal over Amylyx ALS drug

‘Oppenheimer’ and the risks of AI in health care

The high personal cost of affirmative action for Black doctors

Sage hopes for a blockbuster in antidepressant now before FDA

Adults seen as increasingly susceptible to measles

Pence says 'crackpot lawyers' told Trump what he wanted to hear

explore

focus

explore

entertainment